The acquisition of Healint aligns with Aptar Digital Health’s strategy to broaden its portfolio in neurology and strengthen its global footprint for digital health deployment
New facility is part of Aptar Pharma’s global expansion program
Construction will begin this year with the new capacity anticipated by 2025
These announcements are in line with Croda Pharma’s strategy to “Empower Biologics Delivery” and follows news on investments, earlier this year, to expand Croda Pharma’s global manufacturing capabilities to enable the next generation vaccines and therapeutic drugs.
The collaboration between CORONA and Ferring will cater to patients across India
APF Futurity is made from polyolefin materials with no metal parts or recycling disruptors
Laxxon Medical has developed a 3D screen printing technology for the manufacture of structured tablets that enables the controlled release of active pharmaceutical ingredients over time
The R&D centre will endeavour to bring scientifically advanced biological, biotechnology products and novel drug delivery systems
The quarter also saw continued investment in new technologies and the successful implementation of several digitization and automation projects across operations
In the agreement, Marcor, an Azelis Americas company, will distribute the SPI Pharma product lines in the United States, and Azelis Canada Pharma Division will be responsible for the Canadian marketplace
Subscribe To Our Newsletter & Stay Updated
